Open AccessPerformance of automated scoring of ER, PR, HER2, CK5/6 and EGFR in breast cancer tissue microarrays in the Breast Cancer Association Consortium
Author(s) -
Howat William J,
Blows Fiona M,
Provenzano Elena,
Brook Mark N,
Morris Lorna,
Gazinska Patrycja,
Johnson Nicola,
McDuffus LeighAnne,
Miller Jodi,
Sawyer Elinor J,
Pinder Sarah,
Deurzen Carolien H M,
Jones Louise,
Sironen Reijo,
Visscher Daniel,
Caldas Carlos,
Daley Frances,
Coulson Penny,
Broeks Annegien,
Sanders Joyce,
Wesseling Jelle,
Nevanlinna Heli,
Fagerholm Rainer,
Blomqvist Carl,
Heikkilä Päivi,
Ali H Raza,
Dawson SarahJane,
Figueroa Jonine,
Lissowska Jolanta,
Brinton Louise,
Mannermaa Arto,
Kataja Vesa,
Kosma VeliMatti,
Cox Angela,
Brock Ian W,
Cross Simon S,
Reed Malcolm W,
Couch Fergus J,
Olson Janet E,
Devillee Peter,
Mesker Wilma E,
Seyaneve Caroline M,
Hollestelle Antoinette,
Benitez Javier,
Perez Jose Ignacio Arias,
Menéndez Primitiva,
Bolla Manjeet K,
Easton Douglas F,
Schmidt Marjanka K,
Pharoah Paul D,
Sherman Mark E,
GarcíaClosas Montserrat
Publication year - 2015
Publication title -
the journal of pathology: clinical research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.849
H-Index - 21
ISSN - 2056-4538
DOI - 10.1002/cjp2.3
Subject(s) - tissue microarray , breast cancer , cytokeratin , epidermal growth factor receptor , progesterone receptor , oncology , cancer , pathology , kappa , medicine , biology , immunohistochemistry , estrogen receptor , linguistics , philosophy
Abstract Breast cancer risk factors and clinical outcomes vary by tumour marker expression. However, individual studies often lack the power required to assess these relationships, and large‐scale analyses are limited by the need for high throughput, standardized scoring methods. To address these limitations, we assessed whether automated image analysis of immunohistochemically stained tissue microarrays can permit rapid, standardized scoring of tumour markers from multiple studies. Tissue microarray sections prepared in nine studies containing 20 263 cores from 8267 breast cancers stained for two nuclear (oestrogen receptor, progesterone receptor), two membranous (human epidermal growth factor receptor 2 and epidermal growth factor receptor) and one cytoplasmic (cytokeratin 5/6) marker were scanned as digital images. Automated algorithms were used to score markers in tumour cells using the Ariol system. We compared automated scores against visual reads, and their associations with breast cancer survival. Approximately 65–70% of tissue microarray cores were satisfactory for scoring. Among satisfactory cores, agreement between dichotomous automated and visual scores was highest for oestrogen receptor (Kappa = 0.76), followed by human epidermal growth factor receptor 2 (Kappa = 0.69) and progesterone receptor (Kappa = 0.67). Automated quantitative scores for these markers were associated with hazard ratios for breast cancer mortality in a dose‐response manner. Considering visual scores of epidermal growth factor receptor or cytokeratin 5/6 as the reference, automated scoring achieved excellent negative predictive value (96–98%), but yielded many false positives (positive predictive value = 30–32%). For all markers, we observed substantial heterogeneity in automated scoring performance across tissue microarrays. Automated analysis is a potentially useful tool for large‐scale, quantitative scoring of immunohistochemically stained tissue microarrays available in consortia. However, continued optimization, rigorous marker‐specific quality control measures and standardization of tissue microarray designs, staining and scoring protocols is needed to enhance results.